Role of Immune Checkpoints (PD-1, PDL1 and CTLA-4) In Triple-Negative Breast Cancer and Therapeutic Implications

Authors

Institutions

Publication Details

Published
2025-02-13
DOI
https://doi.org/10.9734/irjo/2025/v8i1170
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Role of Immune Checkpoints (PD-1, PDL1 and CTLA-4) In Triple-Negative Breast Cancer and Therapeutic Implications

Orkaa Terungwa Samuel, Daniel Temiloluwa Oyedemi, Adegbesan Abiodun Christopher, O. A. Adedayo et al.
Cancer Immunotherapy and Biomarkers
article

Role of Immune Checkpoints (PD-1, PDL1 and CTLA-4) In Triple-Negative Breast Cancer and Therapeutic Implications

Orkaa Terungwa Samuel, Daniel Temiloluwa Oyedemi, Adegbesan Abiodun Christopher, O. A. Adedayo, Adewoyin Peter Bemigho, Lawrence John AJUTOR, Christian Ajiri Adobor, Blessing Aitebiereme Iyoyojie, Kingsley Ugonna Ugoagwu, Daniel Ebubechi Obasi
article en

Abstract

No abstract available for this paper.
Vol. 8(1)
University of Ibadan (NG), University of Massachusetts Amherst (US), Afe Babalola University (NG)
Good health and well-being
Openalex Percentile: Top 96%
Cancer Immunotherapy and Biomarkers
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.